Kamada Ltd. is a global biopharmaceutical company with a portfolio of marketed products indicated for rare and serious conditions and a leader in the specialty plasma-derived therapies field.
The company’s strategy is focused on driving profitable g…
Analysis
Quality compounder
Kamada Ltd. is a quality compounder: a well-run business trading at a price that reflects what it is worth. One caution: reported profits have recently run ahead of actual cash, which we track closely.
The price is fair. You pay 17.1× its owner earnings: the cash an owner could take out each year, which is in the historically fair zone.
The trajectory is moderate and the balance sheet is sturdy. The company scores 12/20 on our value-creation score: creating some value.
What to watch: Reported profits have run ahead of actual cash for several periods. As always: this describes the company's numbers; it is not a recommendation.
360° rank · history
1007550250
Mar 202687
46
2026
All-time high
87
Mar 2026
All-time low
46
Jun 2026
Average rank
67
across all years
Detailed & Historical Ranks
Deep dive into 15 detailed ranks and 3 years of history.
Current202520242023
Price/Sales
48
—
—
—
Price/Earnings
23
—
—
—
Price/Book
63
—
—
—
Dividend Yield
1
—
—
—
Value (overall)
24
—
—
—
Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.